AKRO
Price
$29.09
Change
+$0.05 (+0.17%)
Updated
Dec 13, 04:12 PM (EDT)
90 days until earnings call
PMVP
Price
$1.60
Change
+$0.02 (+1.27%)
Updated
Dec 13, 01:10 PM (EDT)
75 days until earnings call
Ad is loading...

AKRO vs PMVP

Header iconAKRO vs PMVP Comparison
Open Charts AKRO vs PMVPBanner chart's image
Akero Therapeutics
Price$29.09
Change+$0.05 (+0.17%)
Volume$100
CapitalizationN/A
PMV Pharmaceuticals
Price$1.60
Change+$0.02 (+1.27%)
Volume$102
CapitalizationN/A
AKRO vs PMVP Comparison Chart
Loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AKRO vs. PMVP commentary
Dec 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKRO is a StrongBuy and PMVP is a Hold.

COMPARISON
Comparison
Dec 13, 2024
Stock price -- (AKRO: $29.03 vs. PMVP: $1.58)
Brand notoriety: AKRO and PMVP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AKRO: 60% vs. PMVP: 109%
Market capitalization -- AKRO: $2.03B vs. PMVP: $81.76M
AKRO [@Biotechnology] is valued at $2.03B. PMVP’s [@Biotechnology] market capitalization is $81.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $494.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKRO’s FA Score shows that 0 FA rating(s) are green whilePMVP’s FA Score has 1 green FA rating(s).

  • AKRO’s FA Score: 0 green, 5 red.
  • PMVP’s FA Score: 1 green, 4 red.
According to our system of comparison, AKRO is a better buy in the long-term than PMVP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKRO’s TA Score shows that 4 TA indicator(s) are bullish while PMVP’s TA Score has 3 bullish TA indicator(s).

  • AKRO’s TA Score: 4 bullish, 5 bearish.
  • PMVP’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, AKRO is a better buy in the short-term than PMVP.

Price Growth

AKRO (@Biotechnology) experienced а -2.26% price change this week, while PMVP (@Biotechnology) price change was -0.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.11%. For the same industry, the average monthly price growth was -3.32%, and the average quarterly price growth was +7.36%.

Reported Earning Dates

AKRO is expected to report earnings on Mar 13, 2025.

PMVP is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-3.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AKRO($2.03B) has a higher market cap than PMVP($81.8M). AKRO YTD gains are higher at: 24.325 vs. PMVP (-49.032). PMVP has higher annual earnings (EBITDA): -77.72M vs. AKRO (-232.85M). AKRO has more cash in the bank: 717M vs. PMVP (183M). PMVP has less debt than AKRO: PMVP (13.3M) vs AKRO (36.4M). AKRO (0) and PMVP (0) have equivalent revenues.
AKROPMVPAKRO / PMVP
Capitalization2.03B81.8M2,477%
EBITDA-232.85M-77.72M300%
Gain YTD24.325-49.032-50%
P/E RatioN/AN/A-
Revenue00-
Total Cash717M183M392%
Total Debt36.4M13.3M274%
TECHNICAL ANALYSIS
Technical Analysis
AKROPMVP
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 5 days ago
84%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 30 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
AKRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMVP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CRT10.150.07
+0.69%
Cross Timbers Royalty Trust
MYGN14.50-0.01
-0.07%
Myriad Genetics
MA532.41-2.04
-0.38%
Mastercard
CCBG39.30-0.30
-0.76%
Capital City Bank Group
KBR58.70-0.62
-1.05%
KBR

AKRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, AKRO has been loosely correlated with ETNB. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if AKRO jumps, then ETNB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AKRO
1D Price
Change %
AKRO100%
-4.35%
ETNB - AKRO
62%
Loosely correlated
-2.36%
DNLI - AKRO
45%
Loosely correlated
-1.68%
PLRX - AKRO
44%
Loosely correlated
-2.46%
BEAM - AKRO
43%
Loosely correlated
-2.91%
KROS - AKRO
43%
Loosely correlated
-73.15%
More

PMVP and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMVP has been loosely correlated with MDGL. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PMVP jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMVP
1D Price
Change %
PMVP100%
+0.64%
MDGL - PMVP
44%
Loosely correlated
-1.33%
SEER - PMVP
42%
Loosely correlated
-2.38%
CLLS - PMVP
39%
Loosely correlated
-2.63%
MGTX - PMVP
37%
Loosely correlated
-2.28%
PLRX - PMVP
35%
Loosely correlated
-2.46%
More